Thrive Capital Management, LLC

Position in ELAN — Elanco Animal Health Inc

CIK 1845943 FORT WASHINGTON, PA

Back to ELAN Full portfolio

Position in ELAN

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$4,584,030

+$1,148,065 QoQ

Shares Held

186,267

+29.7% QoQ

Ownership

0.037%

of shares outstanding

% of Portfolio

1.43%

of 13F equity value

Holder Rank

#133

of 515 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in ELAN Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Thrive Capital Management, LLC holds $13,446,022 across 3 Drug Manufacturers - Specialty & Generic names. ELAN ranks #2 (34.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	27,428	$4,622,715
2	ELAN	Elanco Animal Health Inc This page	186,267	$4,584,030
3	UTHR	UNITED THERAPEUTICS Corp	7,824	$4,239,277

All Filings in ELAN

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,584,030	186,267	+29.7%	Shares	Sole	2026-08-05
2026-03-31	$3,435,965	143,584	-8.0%	Shares	Sole	2026-04-27
2025-12-31	$3,530,483	156,009	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.